Status:
TERMINATED
Evaluation of Laser Treatment for Benign Pigmented Lesions by Non-invasive, Cellular Resolution Optical Coherence Tomography
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Collaborating Sponsors:
Apollo Medical Optics, Ltd
Conditions:
Benign Pigmented Lesions
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
In recent years, with the maturity of laser technology, laser therapy is one of the popular options for the treatment of pigment diseases. The absorption spectrum of melanin ranges from 300 to 1,000 n...
Eligibility Criteria
Inclusion
- Age ≧ 20
- Both gender are accepted
- Subject with pigmented diseases
- The pigmented lesions which participating the trial were not treated in the last 12 months
- Accepts not to expose the face to sunlight or artificial UV rays during the study
- Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits
- During the trial period, willing to use the maintenance and sunscreen products provided in this trial for care
Exclusion
- Pregnant woman or woman wishing to be pregnant during the study, or during breastfeeding period
- Has any condition which, in the investigator's opinion, would make it unsafe for participating in this research study
- Has systemic skin disorders or infections
- Is enrolled or accepted other investigational drug or medical device
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 22 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04861246
Start Date
September 15 2021
End Date
March 22 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Beitou District, Taiwan, 11217